LL-37
Cathelicidin · hCAP18 · CAMP
The only human cathelicidin-derived antimicrobial peptide, a 37-residue amphipathic peptide cleaved from the hCAP18 precursor (CAMP gene) whose sequence begins with two leucines. Studied for host-defense, immunomodulatory, angiogenic, and wound-repair activity.
Half-life
Not well characterized in humans; short (endogenous, protease-sensitive peptide). Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Supplied lyophilized; store cold, reconstitute before use, then refrigerate and protect from light.
References
- UniProt P49913 (CAMP)
- Peer-reviewed cathelicidin/LL-37 host-defense reviews
- PubMed: human cathelicidin biology
Related in Healing / Recovery
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.